RASSF1A suppresses oncogenic H-Ras-induced c-Jun N-terminal kinase activation

Abstract

Abstract. The constitutive activation of JNK has been implicated in Ras-induced cellular transformation and activated JNK is down-regulated by the tumor suppressor protein, RASSF1A. In this study, we examined whether RASSF1A blocked oncogenic Ras-induced JNK activation. Exogenous expression of H-Ras G12V induced JNK phosphorylation and RASSF1A co-transfected with H-Ras G12V efficiently suppressed Ras-triggered JNK activation in various cancer cell lines. RASSF1A expression revived the H-Ras G12V -induced p27Kip1 down-regulation. JNK siRNA treatment also promoted recovery from the H-Ras G12V -induced p27 Kip1 downregulation. These results demonstrate that RASSF1A inhibited H-Ras G12V -induced JNK activation and JNK-mediated p27Kip1 down-regulation. From these results, we propose that RASSF1A exerts a tumor-suppressing effect by blocking oncogenic Ras-induced JNK activation.

In vitro exploration of the synergistic effect of alternating magnetic field mediated thermo–chemotherapy with doxorubicin loaded dual pH- and thermo-responsive magnetic nanocomposite carriers

“…Especially, localized hyperthermia has been demonstrated that it can eradicate the carcinoma cells via multiple ways. On the cellular level, the thermal cytotoxicity itself directly kills the cancer cells via irreversible cytoplasmic and membrane proteins denaturation on the molecular level, 1,2 the absorbed heat provokes numerous apoptosis related cellular pathways, which include cytochrome C released mitochondria apoptosis and TNF-related apoptosis-inducing ligand death receptors DR4, DR5 3,4 , or non-apoptotic cell death such as caspase inflammation enzyme activation. 5 Furthermore, the heat shock proteins can also serve as a target motif on the cell membrane for activating and augmenting the immune cell against the targeted cells.…”

Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing?

“…It has been shown that RASSF1A promotes cell cycle arrest by impairing cyclin D1 accumulation [ 112 ] through a mechanism involving EWS-mediated translational regulation and that seems to be dependent on proper RB-E2F regulation [ 108 ]. Additionally, RASSF1A suppresses JNK expression induced by RAS leading to impaired c-Jun phosphorylation, further Cyclin D1 downregulation [ 114 ] and p27 accumulation [ 152 ], promoting arrested cell proliferation. Since enhanced Cyclin D activity leads to aberrant proliferation, being able to control checkpoints throughout the cell cycle phases could also counteract this effect.…”

RNAi-induced K-Ras Gene Silencing Suppresses Growth of EC9706 Cells and Enhances Chemotherapy Sensitivity of Esophageal Cancer

“…The K-Ras gene in the Ras gene family is attracting particular attention because of its high mutation rate. The Ras pathway is a highly conservative signaling pathway, which mediates cell differentiation, proliferation, survival and oncogenic transformation by stimulating various signaling pathways under the action of effector molecules (Song et al, 2005;Cong et al, 2006;Yoo et al, 2006). As an oncogene, Ras induces cancer once it is activated.…”